Stock listing

NASDAQ:ACGN Aceragen Inc. Stock

Follow Aceragen Inc. into a list and get an email when it puts out news.

Delisted NASDAQ:ACGN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ACGN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Felix Baker
Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Ardea Biosciences Inc (Director · Feb 8, 2010 – Jun 19, 2012 · Past); Synageva BioPharma Corp (Director · Aug 14, 2007 – Jun 22, 2015 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Seagen Inc (Director · May 25, 2007 – Dec 14, 2023 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past)
Director · Mar 10, 2014 – Apr 1, 2019 · Past
Julian Baker
Other companies: Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Director · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Managing Partner, Baker Brothers Investments | Chairman, Incyte · Since at least Apr 25, 2006); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Ardea Biosciences Inc (Director · Apr 6, 2010 – Jun 19, 2012 · Past); Seagen Inc (Director · Jun 9, 2006 – Dec 14, 2023 · Past); Innoviva, Inc. (Director · Apr 26, 2006 – Apr 26, 2006 · Past); Genomic Health Inc (Director · Apr 25, 2006 – Oct 1, 2019 · Past); Synageva BioPharma Corp (Director · Apr 25, 2006 – Jun 22, 2015 · Past); Neurogen Corp (Director · Mar 15, 2006 – Dec 15, 2009 · Past)
Director · Mar 10, 2014 – Apr 1, 2019 · Past
Mark Alan Goldberg
Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past)
Director · Jan 7, 2014 – Jun 23, 2022 · Past
Carol A. Schafer
Other companies: Immunome, Inc. (Director · Since at least Jan 2, 2024); Kura Oncology, Inc. (Director · Since at least Jun 3, 2021); Repare Therapeutics Inc (Director · Since at least May 13, 2021); Insmed Incorporated (Director · Since at least May 12, 2021); Five Prime Therapeutics Inc (Director · Apr 16, 2021 – Apr 16, 2021 · Past)
Director · Oct 1, 2020 – Jun 23, 2022 · Past
James Geraghty
Other companies: Fulcrum Therapeutics, Inc. (Board Member · Since at least Jul 17, 2019); Voyager Therapeutics, Inc. (Director · Since at least Jun 15, 2016); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Palvella Therapeutics, Inc. (Director · May 22, 2017 – Dec 12, 2024 · Past); Juniper Pharmaceuticals Inc (Director · Aug 2, 2016 – Aug 14, 2018 · Past)
Director · May 13, 2016 – Jun 23, 2022 · Past
Kelvin Neu
Other companies: Theravance Biopharma, Inc. (MD, PhD · Since at least Nov 5, 2026); Zymeworks Inc. (Director · Since at least Mar 16, 2020); Prelude Therapeutics Incorporated (Director · Sep 24, 2020 – Sep 24, 2020 · Past); IGM Biosciences Inc (Director · Sep 17, 2019 – Sep 17, 2019 · Past); Neurogene Inc. (Director · Mar 23, 2017 – Mar 23, 2017 · Past)
Director · Mar 10, 2014 – Mar 10, 2014 · Past
Maxine Gowen
Other companies: Passage Bio, Inc. (Chairwoman · Since at least Feb 18, 2021); Aclaris Therapeutics, Inc. (Director · Since at least Jul 2, 2019); Trevena, Inc. (Director · Since at least Jan 30, 2014); Akebia Therapeutics, Inc. (Director · Jul 28, 2014 – Jun 5, 2020 · Past); Human Genome Sciences Inc (Director · Feb 15, 2008 – Jul 30, 2012 · Past)
Director · Jan 4, 2015 – Aug 10, 2023 · Past
Vincent Milano
Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Jul 26, 2021); Aclaris Therapeutics, Inc. (Director · Since at least Jan 7, 2020); Spark Therapeutics Inc (Director · Jan 29, 2015 – Dec 17, 2019 · Past); Viropharma Inc (President and CEO, Director · Jun 7, 2010 – Jan 24, 2014 · Past); Vanda Pharmaceuticals Inc. (Director · Apr 21, 2010 – Jun 13, 2018 · Past)
Director · Dec 1, 2014 – Aug 10, 2023 · Past
Daniel B Soland
Other companies: ACADIA Pharmaceuticals Inc. (Director · Since at least Mar 20, 2015); DBV Technologies SA (Director · Jan 1, 2021 – Aug 1, 2023 · Past); KalVista Pharmaceuticals, Inc. (Director · Apr 22, 2019 – Sep 30, 2021 · Past); Viropharma Inc (VP, Chief Operating Officer · Nov 6, 2006 – Jan 24, 2014 · Past)
CHIEF OPERATING OFFICER · Jan 4, 2021 – Jul 6, 2022 · Past
Louis Md Brenner
Other companies: Allena Pharmaceuticals Inc (President and CEO, Director · Nov 1, 2017 – Feb 1, 2022 · Past); Radius Health, Inc. (Chief Medical Officer · Nov 9, 2011 – Dec 15, 2011 · Past); AMAG Pharmaceuticals Inc (Senior Vice President · Feb 6, 2007 – Feb 26, 2008 · Past)
Chief Medical Officer · Jan 6, 2014 – Dec 10, 2014 · Past
All 25 people
PersonSeat
John Peter Wolf III
Other companies: Nabriva Therapeutics AG (General Counsel and Corp. Sec. · Dec 30, 2016 – Dec 30, 2016 · Past); Viropharma Inc (VP, General Counsel · Jun 10, 2013 – Jan 24, 2014 · Past)
General Counsel · Dec 10, 2014 – Dec 10, 2014 · Past
Bryant Lim
Other companies: Prelude Therapeutics Incorporated (Chief Financial Officer & Chief Legal Officer · Since at least Feb 20, 2023)
SVP AND GENERAL COUNSEL · Sep 10, 2018 – Jan 20, 2023 · Past
Carl N Kraus
Other companies: Aquestive Therapeutics, Inc. (Chief Medical Officer · Since at least Jun 26, 2023)
CHIEF MEDICAL OFFICER · Sep 28, 2022 – Jan 20, 2023 · Past
Daniel Salain
Other companies: CalciMedica, Inc. (CTOO · Sep 24, 2020 – Dec 8, 2020 · Past)
CHIEF OPERATING OFFICER · Sep 28, 2022 – Jan 20, 2023 · Past
Louis J Arcudi III
Other companies: Tempest Therapeutics, Inc. (President and CEO, Director · Dec 7, 2018 – Feb 26, 2021 · Past)
Chief Financial Officer · Jan 3, 2017 – Aug 13, 2018 · Past
Ronald J Wooten
Other companies: Revance Therapeutics, Inc. (Director · Feb 5, 2014 – May 7, 2015 · Past)
Director · Sep 28, 2022 – Jan 17, 2023 · Past
Alice BexonV.P. Clinical Development · Dec 16, 2008 – Dec 23, 2009 · Past
Andrew R JordanCHIEF STRATEGY OFFICER · Sep 28, 2022 – Jan 20, 2023 · Past
Elizabeth Ann TarkaCHIEF MEDICAL OFFICER · Jul 22, 2019 – Mar 25, 2021 · Past
John Clayton TaylorCHIEF EXECUTIVE OFFICER, Director · Sep 28, 2022 – Jan 20, 2023 · Past
Jonathan Michael YinglingChief Scientific Officer · Jul 9, 2019 – Jan 10, 2020 · Past
Paul C ZamecnikDirector · Jan 1, 2006 – Jul 2, 2007 · Past
Robert C FletcherSr. VP, Bus. Dev. & Strategy · Jan 3, 2017 – Jul 21, 2020 · Past
Sudhir AgrawalPresident of Research, Director · Jan 6, 2016 – Jan 3, 2017 · Past
Timothy M SullivanVP Development Programs · Jun 7, 2006 – May 27, 2014 · Past

Open People

Log in to ask 6ix AI your own questions about Aceragen Inc.